1. Cilgavimab/tixagevimab unlikely to be active against some COVID-19 Omicron subvariants

   News item 28 January 2023 Pages: 1 - 1

2. Donepezil may cause QT prolongation and torsades de pointes

   News item 28 January 2023 Pages: 2 - 2

3. Health Canada removes seven unauthorised health products from sale

   News item 28 January 2023 Pages: 3 - 3

4. PRAC meeting highlights 9−12 January 2023

   News item 28 January 2023 Pages: 4 - 4

5. Precautions for use of hydroxyethyl starch revised in Japan

   News item 28 January 2023 Pages: 5 - 5

6. Spectrum Laboratory Products recalls 3 lots of discoloured epinephrine

   News item 28 January 2023 Pages: 6 - 6

7. AEs associated with accidental sodium oxybate dosing errors

   Clinical study 28 January 2023 Pages: 7 - 7

8. Beta-blockers increase risk of HF hospitalisation after AV node ablation

   Clinical study 28 January 2023 Pages: 8 - 8

9. Buprenorphine safer than methadone in pregnant women with opioid use disorder

   Clinical study 28 January 2023 Pages: 9 - 9

10. HER-2 inhibitor-related cardiovascular adverse events

    Clinical study 28 January 2023 Pages: 10 - 10

11. RAASi-associated hyperkalaemia: increased risk of adverse outcomes

    Clinical study 28 January 2023 Pages: 11 - 11

12. Safety of co-administered mRNA COVID-19 and influenza vaccines

    Clinical study 28 January 2023 Pages: 12 - 12

13. Other adverse reaction research

    News item 28 January 2023 Pages: 13 - 13

14. Acenocoumarol/phenprocoumon

    Case report 28 January 2023 Pages: 14 - 14

15. Adalimumab

    Case report 28 January 2023 Pages: 15 - 15

16. Adalimumab

    Case report 28 January 2023 Pages: 16 - 16

17. Adalimumab

    Case report 28 January 2023 Pages: 17 - 17

18. Adalimumab/infliximab

    Case report 28 January 2023 Pages: 18 - 18

19. Adalimumab/methotrexate

    Case report 28 January 2023 Pages: 19 - 19

20. Adenosine

    Case report 28 January 2023 Pages: 20 - 20

21. Adenosine

    Case report 28 January 2023 Pages: 21 - 21

22. Aducanumab/donepezil/memantine

    Case report 28 January 2023 Pages: 22 - 22

23. Aflibercept/bevacizumab/triamcinolone

    Case report 28 January 2023 Pages: 23 - 23

24. Ajmaline/flecainide

    Case report 28 January 2023 Pages: 24 - 24

25. Albumins/antibacterials/immunoglobulin G

    Case report 28 January 2023 Pages: 25 - 25

26. Alogliptin

    Case report 28 January 2023 Pages: 26 - 26

27. Alpelisib

    Case report 28 January 2023 Pages: 27 - 27

28. Alteplase/plasma/tranexamic-acid

    Case report 28 January 2023 Pages: 28 - 28

29. Amiodarone/clopidogrel

    Case report 28 January 2023 Pages: 29 - 29

30. Amiodarone/dofetilide/mexiletine

    Case report 28 January 2023 Pages: 30 - 30

31. Amiodarone/sirolimus

    Case report 28 January 2023 Pages: 31 - 31

32. Amlodipine/benazepril/aspirin

    Case report 28 January 2023 Pages: 32 - 32

33. Amoxicillin/bumetanide

    Case report 28 January 2023 Pages: 33 - 33

34. Amphotericin-B

    Case report 28 January 2023 Pages: 34 - 34

35. Amphotericin-B/fingolimod

    Case report 28 January 2023 Pages: 35 - 35

36. Anakinra

    Case report 28 January 2023 Pages: 36 - 36

37. Anakinra/ciclosporin/methylprednisolone

    Case report 28 January 2023 Pages: 37 - 37

38. Anakinra/immune-globulin/steroids

    Case report 28 January 2023 Pages: 38 - 38

39. Antibacterials

    Case report 28 January 2023 Pages: 39 - 39

40. Antibacterials/antineoplastics

    Case report 28 January 2023 Pages: 40 - 40

41. Antibacterials/betamethasone/oxytocin

    Case report 28 January 2023 Pages: 41 - 41

42. Antibacterials/dexamethasone/tocilizumab

    Case report 28 January 2023 Pages: 42 - 42

43. Antibacterials/loteprednol-etabonate

    Case report 28 January 2023 Pages: 43 - 43

44. Antibacterials/prednisolone

    Case report 28 January 2023 Pages: 44 - 44

45. Antiepileptic-drugs

    Case report 28 January 2023 Pages: 45 - 45

46. Antifungals

    Case report 28 January 2023 Pages: 46 - 46

47. Antihyperglycaemics

    Case report 28 January 2023 Pages: 47 - 47

48. Antineoplastics

    Case report 28 January 2023 Pages: 48 - 48

49. Antineoplastics

    Case report 28 January 2023 Pages: 49 - 49

50. Antineoplastics

    Case report 28 January 2023 Pages: 50 - 50